Partnerships for the Development of Universal Influenza Vaccines (R21/R33)
| קרן | National Institute of Allergy and Infectious Diseases/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants, Partnership Activities |
| תאריך אחרון | 02/07/2020 |
| פקולטה | Life Sciences, Medicine, Social Sciences |
| תיאור | The purpose of this grant is to solicit applications to support development of promising universal influenza vaccine candidates that protect against both influenza A and B viruses.
Funding: R21 $275,000 total ; R3 $300,000 per year Duration: R21 2 years; R33 3 years
Research Authority due date: 26.5.20 LOI (encouraged) due date: 2.6.20 Full proposal due date: 2.7.20 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 03/03/2020 |
